Compare Abeona Therapeutics Inc (ABEO) vs InMode Ltd (INMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs InMode Ltd — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while InMode Ltd trades at $15.16 (market cap $872.08M). The key difference: InMode Ltd is far larger — about 2.1× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, InMode Ltd nearer its low. Which is the better fit depends on your goals.
| ABEO | INMD | |
|---|---|---|
Market Cap | $421.19M | $872.08M |
Sector | Health | Technology |
52-Week High | $7.45 | $16.62 |
52-Week Low | $4.17 | $12.76 |
Enterprise Value | $276.10M | $375.42M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About InMode Ltd
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →
